Jan Sjövall

Author PubWeight™ 30.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cholestenoic acids regulate motor neuron survival via liver X receptors. J Clin Invest 2014 1.55
2 Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain. Mol Cell Proteomics 2004 1.46
3 Cerebrospinal fluid steroidomics: are bioactive bile acids present in brain? J Biol Chem 2009 1.23
4 Fxr(-/-) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids. J Lipid Res 2005 1.22
5 Analysis of oxysterols by electrospray tandem mass spectrometry. J Am Soc Mass Spectrom 2006 1.20
6 Bile acids: analysis in biological fluids and tissues. J Lipid Res 2010 1.16
7 Discovering oxysterols in plasma: a window on the metabolome. J Proteome Res 2008 1.14
8 Pregnenolone sulfate in the brain: a controversial neurosteroid. Neurochem Int 2007 1.13
9 Liquid chromatography-mass spectrometry utilizing multi-stage fragmentation for the identification of oxysterols. J Lipid Res 2007 1.11
10 Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis. Nat Chem Biol 2012 1.09
11 Derivatisation for the characterisation of neutral oxosteroids by electrospray and matrix-assisted laser desorption/ionisation tandem mass spectrometry: the Girard P derivative. Rapid Commun Mass Spectrom 2003 1.07
12 Neurosteroids in rat brain: extraction, isolation, and analysis by nanoscale liquid chromatography-electrospray mass spectrometry. Anal Chem 2003 1.06
13 The effect of 24S-hydroxycholesterol on cholesterol homeostasis in neurons: quantitative changes to the cortical neuron proteome. J Proteome Res 2008 1.04
14 Novel lipoidal derivatives of pregnenolone and dehydroepiandrosterone and absence of their sulfated counterparts in rodent brain. J Lipid Res 2004 1.03
15 Targeted lipidomic analysis of oxysterols in the embryonic central nervous system. Mol Biosyst 2009 0.96
16 PU.1 and bacterial metabolites regulate the human gene CAMP encoding antimicrobial peptide LL-37 in colon epithelial cells. Mol Immunol 2008 0.91
17 On-column electrochemical reactions accompanying the electrospray process. Anal Chem 2003 0.90
18 Matrix-assisted laser desorption/ionization high-energy collision-induced dissociation of steroids: analysis of oxysterols in rat brain. Anal Chem 2006 0.87
19 Capillary liquid chromatography/electrospray mass spectrometry for analysis of steroid sulfates in biological samples. Anal Chem 2003 0.86
20 Mutation in the sterol 27-hydroxylase gene associated with fatal cholestasis in infancy. J Pediatr Gastroenterol Nutr 2005 0.84
21 Analysis of pregnenolone and dehydroepiandrosterone in rodent brain: cholesterol autoxidation is the key. J Lipid Res 2009 0.84
22 Analysis of derivatised steroids by matrix-assisted laser desorption/ionisation and post-source decay mass spectrometry. Steroids 2005 0.81
23 Analytical strategies for characterization of bile acid and oxysterol metabolomes. Biochem Biophys Res Commun 2010 0.81
24 Continuous interscalene analgesia with ropivacaine 2 mg/ml after major shoulder surgery. Anesthesiology 2003 0.81
25 Specificity of receptor-ligand interactions and their effect on dimerisation as observed by electrospray mass spectrometry: bile acids form stable adducts to the RXRalpha. J Mass Spectrom 2005 0.80
26 Electrospray mass spectrometry for the direct accurate mass measurement of ligands in complex with the retinoid X receptor alpha ligand binding domain. J Am Soc Mass Spectrom 2005 0.80
27 Ethanol stimulates bile acid formation in primary human hepatocytes. Biochem Biophys Res Commun 2007 0.80
28 High-energy collision-induced dissociation of oxosteroids derivatised to Girard hydrazones. Eur J Mass Spectrom (Chichester, Eng) 2004 0.80
29 Rectal ropivacaine is absorbed proportionally to the dose, with low intraindividual variability. Br J Clin Pharmacol 2003 0.78
30 Detection of a receptor-ligand non-covalent complex using a triple quadrupole mass spectrometer. Rapid Commun Mass Spectrom 2002 0.77
31 Pharmacokinetics of ropivacaine in patients with chronic end-stage liver disease. Anesthesiology 2007 0.77